References
- Castle WB: Observations on the etiologic relationship of achylia gastrica to pernicious anemia. Am J Med Sci 178,748–764, 1929.
- McIntyre PA, Sachs MV, Krevans JR, Conley CL: Pathogenesis and treatment of macrocytic anemia. Arch Intern Med 98: 541–549, 1956.
- Schjonsby H: Vitamin B12 absorption and malabsorption. Gut 30, 1686–1691, 1989.
- Festen HPM: Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol 26(Suppl 188), 1–7, 1991.
- Allen RH, Seetharam B, Podell E, Alpers DH: Effect of proteolytic enzymes on the binding of cobalamin to R protein and intrinsic factor. In vitro evidence that a failure to partially degrade R protein is responsible for cobalamin malabsorption in pancreatic insufficiency. J Clin Invest 61: 47–54, 1978.
- Hagedorn CH, Alpers DH: Distribution of intrinsic factor-vitamin B12 receptors in human intestine. Gastroenterology 73: 1019–1022, 1977.
- Robertson JA, Gallagher ND: In vivo evidence that cobalamin is absorbed by receptor mediated endocytosis in the mouse. Gastroenterology 88: 908–912, 1985.
- Saltzman JR, Kemp JA, Golur RN et al.: Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein bound vitamin B12 absorption. J Am Coll Nutr 13: Vol—; pages—, 1994.
- Kittang E, Aadland E, Schjonsby H, Rohss K: The effect of omeprazole on gastric acidity and the absorption of liver cobalamins. Scand J Gastroenterol 22, 156–160, 1987.
- Marcuard SP, Albernaz L, Khazanie PG: Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 120: 211–215, 1994.
- Maton PN, Vinayek R, Frucht H, McArthur KA, Miller LS, Saeed ZA, et al.: Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology 97: 827–36, 1989.
- Klinkenberg-Knol EC, Festen HBM, Jansen JBMJ et al.: Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Int Med 121: 161–167, 1994.